Vanguard Group
VTAK icon

Vanguard Group’s Catheter Precision VTAK Stock Holding History

Vanguard Group’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$28.7K Buy
+15,660
New +$36K ﹤0.01% 4290
2022
Q4 		– Sell
-23
Closed -$27K – 4557
2022
Q3 		$27K Sell
23
-13
-36% -$24.7K ﹤0.01% 4581
2022
Q2 		$106K Hold
36
– – ﹤0.01% 4542
2022
Q1 		$136K Buy
36
+20
+125% +$136K ﹤0.01% 4578
2021
Q4 		$233K Hold
16
– – ﹤0.01% 4541
2021
Q3 		$471K Buy
16
+1
+7% +$31.4K ﹤0.01% 4384
2021
Q2 		$634K Buy
15
+11
+275% +$457K ﹤0.01% 4231
2021
Q1 		$180K Buy
+4
New +$261K ﹤0.01% 4274
2020
Q4 		– Hold
0
– -$27K – 4221
2020
Q3 		– Sell
-1
Closed -$79.6K – 4090
2020
Q2 		$71K Hold
1
– – ﹤0.01% 4011
2020
Q1 		$158K Hold
1
– – ﹤0.01% 3894
2019
Q4 		$166K Hold
1
– – ﹤0.01% 3963
2019
Q3 		$206K Buy
+1
New +$540K ﹤0.01% 3957
2019
Q2 		– Sell
-1
Closed -$911K – 3906
2019
Q1 		$761K Hold
1
– – ﹤0.01% 3694
2018
Q4 		$1.77M Buy
+1
New +$2.36M ﹤0.01% 3413

Other funds holding VTAK

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.42B AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Vanguard Group's VTAK Position: Q4 2025 in Review

Vanguard Group opened a new position in Catheter Precision (VTAK) in Q4 2025: 15,660 shares worth $28.7K. The stake represents ﹤0.01% of the portfolio and ranks #4290 among its holdings. This is a return to the name: Vanguard Group previously reported a position in VTAK as recently as Q3 2022.

Vanguard Group first reported a position in VTAK in Q4 2018 and has held it in 14 quarters since. The position peaked at $1.77M in Q4 2018. 9 funds tracked by Wall St. Rank hold VTAK as of Q4 2025.

  • Vanguard Group held 15,660 shares of Catheter Precision worth $28.7K as of Q4 2025.
  • Catheter Precision was a new Vanguard Group position in Q4 2025.
  • Catheter Precision made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4290 holding.
  • Vanguard Group first reported a position in Catheter Precision in Q4 2018 and has held it in 14 quarters since.
  • Vanguard Group's Catheter Precision position peaked at $1.77M in Q4 2018.
  • 9 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.